

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 6.43603315 |
| 2 | oxidative phosphorylation (GO:0006119) | 5.82805646 |
| 3 | proline biosynthetic process (GO:0006561) | 5.41668255 |
| 4 | lysine catabolic process (GO:0006554) | 5.22338834 |
| 5 | lysine metabolic process (GO:0006553) | 5.22338834 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.19856973 |
| 7 | carnitine shuttle (GO:0006853) | 4.87618210 |
| 8 | NADH metabolic process (GO:0006734) | 4.78789299 |
| 9 | protein maturation by protein folding (GO:0022417) | 4.78508059 |
| 10 | ATP synthesis coupled proton transport (GO:0015986) | 4.75056991 |
| 11 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.75056991 |
| 12 | sarcomere organization (GO:0045214) | 4.72820790 |
| 13 | proline metabolic process (GO:0006560) | 4.64466137 |
| 14 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.51288211 |
| 15 | fatty acid transmembrane transport (GO:1902001) | 4.47220039 |
| 16 | 2-oxoglutarate metabolic process (GO:0006103) | 4.47098479 |
| 17 | aspartate family amino acid catabolic process (GO:0009068) | 4.36447843 |
| 18 | transcription from mitochondrial promoter (GO:0006390) | 4.34164659 |
| 19 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.34137589 |
| 20 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.30124679 |
| 21 | fatty acid beta-oxidation (GO:0006635) | 4.24605618 |
| 22 | GDP-mannose metabolic process (GO:0019673) | 4.23883272 |
| 23 | Golgi transport vesicle coating (GO:0048200) | 4.23060824 |
| 24 | COPI coating of Golgi vesicle (GO:0048205) | 4.23060824 |
| 25 | regulation of mitochondrial translation (GO:0070129) | 4.21760424 |
| 26 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.14528942 |
| 27 | cardiac myofibril assembly (GO:0055003) | 4.13404987 |
| 28 | glyoxylate metabolic process (GO:0046487) | 4.06895789 |
| 29 | nucleobase-containing small molecule interconversion (GO:0015949) | 4.04679728 |
| 30 | * respiratory electron transport chain (GO:0022904) | 4.02693302 |
| 31 | acetyl-CoA metabolic process (GO:0006084) | 3.99617618 |
| 32 | muscle filament sliding (GO:0030049) | 3.99301906 |
| 33 | actin-myosin filament sliding (GO:0033275) | 3.99301906 |
| 34 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.97735707 |
| 35 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.96727813 |
| 36 | DNA unwinding involved in DNA replication (GO:0006268) | 3.96352548 |
| 37 | DNA deamination (GO:0045006) | 3.92343013 |
| 38 | * electron transport chain (GO:0022900) | 3.90609340 |
| 39 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.90308961 |
| 40 | branched-chain amino acid catabolic process (GO:0009083) | 3.89064490 |
| 41 | tricarboxylic acid metabolic process (GO:0072350) | 3.87110974 |
| 42 | regulation of coenzyme metabolic process (GO:0051196) | 3.84858812 |
| 43 | regulation of cofactor metabolic process (GO:0051193) | 3.84858812 |
| 44 | formation of translation preinitiation complex (GO:0001731) | 3.80052061 |
| 45 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.79380569 |
| 46 | ribosomal small subunit biogenesis (GO:0042274) | 3.77301838 |
| 47 | cardiac muscle contraction (GO:0060048) | 3.76045228 |
| 48 | oxaloacetate metabolic process (GO:0006107) | 3.75879623 |
| 49 | cardiac muscle cell development (GO:0055013) | 3.70692249 |
| 50 | carnitine transmembrane transport (GO:1902603) | 3.69955645 |
| 51 | amino-acid betaine transport (GO:0015838) | 3.66041923 |
| 52 | carnitine transport (GO:0015879) | 3.66041923 |
| 53 | succinate metabolic process (GO:0006105) | 3.64191797 |
| 54 | branched-chain amino acid metabolic process (GO:0009081) | 3.62017408 |
| 55 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.59989548 |
| 56 | mitochondrial fusion (GO:0008053) | 3.58084088 |
| 57 | fatty acid oxidation (GO:0019395) | 3.56594502 |
| 58 | fatty acid catabolic process (GO:0009062) | 3.56385975 |
| 59 | myofibril assembly (GO:0030239) | 3.53905612 |
| 60 | sulfur amino acid catabolic process (GO:0000098) | 3.52991292 |
| 61 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.48173231 |
| 62 | lipid oxidation (GO:0034440) | 3.47768358 |
| 63 | biotin metabolic process (GO:0006768) | 3.47379626 |
| 64 | protein retention in ER lumen (GO:0006621) | 3.46517645 |
| 65 | histone arginine methylation (GO:0034969) | 3.45952075 |
| 66 | monosaccharide biosynthetic process (GO:0046364) | 3.43794520 |
| 67 | cardiac cell development (GO:0055006) | 3.42211782 |
| 68 | DNA strand elongation (GO:0022616) | 3.39070846 |
| 69 | cellular ketone body metabolic process (GO:0046950) | 3.37634631 |
| 70 | establishment of integrated proviral latency (GO:0075713) | 3.33818537 |
| 71 | valine metabolic process (GO:0006573) | 3.33013914 |
| 72 | mitotic nuclear envelope reassembly (GO:0007084) | 3.32775446 |
| 73 | nuclear envelope reassembly (GO:0031468) | 3.32775446 |
| 74 | short-chain fatty acid metabolic process (GO:0046459) | 3.29221979 |
| 75 | regulation of fatty acid oxidation (GO:0046320) | 3.28203191 |
| 76 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.26569557 |
| 77 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.26070093 |
| 78 | pentose-phosphate shunt (GO:0006098) | 3.24751336 |
| 79 | carnitine metabolic process (GO:0009437) | 3.21746588 |
| 80 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.19885077 |
| 81 | L-phenylalanine metabolic process (GO:0006558) | 3.19836992 |
| 82 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.19836992 |
| 83 | peptidyl-arginine methylation (GO:0018216) | 3.19274692 |
| 84 | peptidyl-arginine N-methylation (GO:0035246) | 3.19274692 |
| 85 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.15228872 |
| 86 | ATP biosynthetic process (GO:0006754) | 3.13837256 |
| 87 | regulation of sequestering of triglyceride (GO:0010889) | 3.12717527 |
| 88 | amino-acid betaine metabolic process (GO:0006577) | 3.11600657 |
| 89 | monocarboxylic acid catabolic process (GO:0072329) | 3.11314210 |
| 90 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.10262298 |
| 91 | mitochondrial DNA metabolic process (GO:0032042) | 3.10107509 |
| 92 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.09919399 |
| 93 | regulation of skeletal muscle contraction (GO:0014819) | 3.08945107 |
| 94 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.08900607 |
| 95 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.08818176 |
| 96 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.07633543 |
| 97 | actin-mediated cell contraction (GO:0070252) | 3.07322622 |
| 98 | establishment of viral latency (GO:0019043) | 3.07125893 |
| 99 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.04363283 |
| 100 | quinone biosynthetic process (GO:1901663) | 3.03661564 |
| 101 | ubiquinone biosynthetic process (GO:0006744) | 3.03661564 |
| 102 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.01335321 |
| 103 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.00118696 |
| 104 | quaternary ammonium group transport (GO:0015697) | 2.99324350 |
| 105 | glycolytic process (GO:0006096) | 2.97792969 |
| 106 | glucose catabolic process (GO:0006007) | 2.96930731 |
| 107 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.96881341 |
| 108 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.96770049 |
| 109 | protein targeting to mitochondrion (GO:0006626) | 2.96639154 |
| 110 | regulation of sulfur metabolic process (GO:0042762) | 2.96502741 |
| 111 | glycine metabolic process (GO:0006544) | 2.96461050 |
| 112 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.96286484 |
| 113 | mitochondrial RNA metabolic process (GO:0000959) | 2.96143572 |
| 114 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.95623864 |
| 115 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.95592269 |
| 116 | negative regulation of ligase activity (GO:0051352) | 2.95592269 |
| 117 | creatine metabolic process (GO:0006600) | 2.94986062 |
| 118 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.94590205 |
| 119 | cysteine metabolic process (GO:0006534) | 2.94510542 |
| 120 | regulation of translational termination (GO:0006449) | 2.94047514 |
| 121 | gluconeogenesis (GO:0006094) | 2.93735680 |
| 122 | maturation of SSU-rRNA (GO:0030490) | 2.92607195 |
| 123 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.92228397 |
| 124 | ribosome biogenesis (GO:0042254) | 2.91584084 |
| 125 | ketone body metabolic process (GO:1902224) | 2.90990945 |
| 126 | serine family amino acid catabolic process (GO:0009071) | 2.90302802 |
| 127 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.90170608 |
| 128 | regulation of translational fidelity (GO:0006450) | 2.87895465 |
| 129 | DNA replication initiation (GO:0006270) | 2.87589724 |
| 130 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.87017611 |
| 131 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.87017611 |
| 132 | plasma membrane repair (GO:0001778) | 2.86375575 |
| 133 | mitotic chromosome condensation (GO:0007076) | 2.86133715 |
| 134 | folic acid metabolic process (GO:0046655) | 2.85637334 |
| 135 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.85099297 |
| 136 | 4-hydroxyproline metabolic process (GO:0019471) | 2.85083382 |
| 137 | NADPH regeneration (GO:0006740) | 2.84862790 |
| 138 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.84778191 |
| 139 | nucleotide salvage (GO:0043173) | 2.84677393 |
| 140 | actomyosin structure organization (GO:0031032) | 2.84627260 |
| 141 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.84530319 |
| 142 | kynurenine metabolic process (GO:0070189) | 2.84324770 |
| 143 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.83649928 |
| 144 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.82999482 |
| 145 | striated muscle contraction (GO:0006941) | 2.80560236 |
| 146 | ribosomal large subunit biogenesis (GO:0042273) | 2.79689861 |
| 147 | negative regulation of cell size (GO:0045792) | 2.79581025 |
| 148 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.78915654 |
| 149 | ribosome assembly (GO:0042255) | 2.78255443 |
| 150 | viral transcription (GO:0019083) | 2.77770641 |
| 151 | heart process (GO:0003015) | 2.77061963 |
| 152 | heart contraction (GO:0060047) | 2.77061963 |
| 153 | heart trabecula formation (GO:0060347) | 2.76885578 |
| 154 | hexose biosynthetic process (GO:0019319) | 2.75429212 |
| 155 | galactose catabolic process (GO:0019388) | 2.74911260 |
| 156 | ethanol oxidation (GO:0006069) | 2.74234742 |
| 157 | heme biosynthetic process (GO:0006783) | 2.74051429 |
| 158 | establishment of protein localization to mitochondrion (GO:0072655) | 2.73768529 |
| 159 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.73209643 |
| 160 | proteasome assembly (GO:0043248) | 2.72777732 |
| 161 | glycogen catabolic process (GO:0005980) | 2.72550481 |
| 162 | pentose metabolic process (GO:0019321) | 2.72436442 |
| 163 | metallo-sulfur cluster assembly (GO:0031163) | 2.70337836 |
| 164 | iron-sulfur cluster assembly (GO:0016226) | 2.70337836 |
| 165 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.69848763 |
| 166 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.68751521 |
| 167 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.68655103 |
| 168 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.65833973 |
| 169 | translational elongation (GO:0006414) | 2.65072940 |
| 170 | UTP biosynthetic process (GO:0006228) | 2.59638090 |
| 171 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.59236411 |
| 172 | regulation of cellular respiration (GO:0043457) | 2.59094326 |
| 173 | rRNA transcription (GO:0009303) | 2.59042188 |
| 174 | aerobic respiration (GO:0009060) | 2.58729275 |
| 175 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.58132700 |
| 176 | translational termination (GO:0006415) | 2.57875881 |
| 177 | pseudouridine synthesis (GO:0001522) | 2.56052098 |
| 178 | ribosomal small subunit assembly (GO:0000028) | 2.55961565 |
| 179 | cellular component biogenesis (GO:0044085) | 2.54255138 |
| 180 | protein localization to mitochondrion (GO:0070585) | 2.53894629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.46738458 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.11259901 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.86110936 |
| 4 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.05923394 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.00877183 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.88258331 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.83950415 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.83240009 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.66692673 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40320168 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.29745372 |
| 12 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.18308097 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.14405629 |
| 14 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.11494722 |
| 15 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.08271892 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.95514117 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.92826780 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88245830 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.84704378 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.81816056 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.77915796 |
| 22 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.72632585 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.66184127 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.65031287 |
| 25 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.64722154 |
| 26 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.64472700 |
| 27 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.62489349 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62450250 |
| 29 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.59199083 |
| 30 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.58902259 |
| 31 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.58504740 |
| 32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.57610345 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.57005752 |
| 34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55851564 |
| 35 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.54869574 |
| 36 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.49445621 |
| 37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.47950216 |
| 38 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47340288 |
| 39 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44626971 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43239626 |
| 41 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.42629250 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42377249 |
| 43 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.42332068 |
| 44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.42127373 |
| 45 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.40485155 |
| 46 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.39237901 |
| 47 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37502588 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36810274 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.35554297 |
| 50 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.34476401 |
| 51 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.33307266 |
| 52 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.32978458 |
| 53 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.32296453 |
| 54 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31524494 |
| 55 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.31325458 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31095369 |
| 57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29196310 |
| 58 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.28933640 |
| 59 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.28921550 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.28458940 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25606257 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23598401 |
| 63 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.23533978 |
| 64 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.23524614 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23369501 |
| 66 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.22945732 |
| 67 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.21769559 |
| 68 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.21632152 |
| 69 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.21525699 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.20110142 |
| 71 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19464406 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19260590 |
| 73 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.18910907 |
| 74 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.18852668 |
| 75 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18125832 |
| 76 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.17809137 |
| 77 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17532755 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17121762 |
| 79 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.16242434 |
| 80 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.16047807 |
| 81 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14938681 |
| 82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14633681 |
| 83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14180374 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13756919 |
| 85 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.13606447 |
| 86 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.13576746 |
| 87 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.13087856 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11948844 |
| 89 | * MYC_22102868_ChIP-Seq_BL_Human | 1.10969661 |
| 90 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10679139 |
| 91 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.10410243 |
| 92 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.10359812 |
| 93 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.09987584 |
| 94 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09059173 |
| 95 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.08816152 |
| 96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08438375 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07746811 |
| 98 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07284533 |
| 99 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.06814887 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06809866 |
| 101 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06655578 |
| 102 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06375464 |
| 103 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.05566427 |
| 104 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.04990926 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04570293 |
| 106 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04559182 |
| 107 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.04393551 |
| 108 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.04233538 |
| 109 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.03945010 |
| 110 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03746988 |
| 111 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03326380 |
| 112 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.03112193 |
| 113 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.02524489 |
| 114 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02207598 |
| 115 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01796438 |
| 116 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00686983 |
| 117 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.99318032 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98892111 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98892111 |
| 120 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98296341 |
| 121 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98188384 |
| 122 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96670028 |
| 123 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96182563 |
| 124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95935066 |
| 125 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95680029 |
| 126 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95333927 |
| 127 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93335322 |
| 128 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93024850 |
| 129 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92130586 |
| 130 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.91598033 |
| 131 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91580242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.43559689 |
| 2 | MP0003646_muscle_fatigue | 4.30970861 |
| 3 | MP0004084_abnormal_cardiac_muscle | 3.85801033 |
| 4 | MP0000751_myopathy | 3.65410156 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.60305926 |
| 6 | MP0005330_cardiomyopathy | 3.46997026 |
| 7 | MP0005360_urolithiasis | 3.23017970 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.21827637 |
| 9 | MP0000749_muscle_degeneration | 2.88495157 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.87767030 |
| 11 | MP0006036_abnormal_mitochondrial_physio | 2.83504607 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.80195514 |
| 13 | MP0004036_abnormal_muscle_relaxation | 2.75134984 |
| 14 | MP0002269_muscular_atrophy | 2.56467834 |
| 15 | MP0004233_abnormal_muscle_weight | 2.50936859 |
| 16 | MP0005365_abnormal_bile_salt | 2.45368644 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.44648819 |
| 18 | MP0004130_abnormal_muscle_cell | 2.36075026 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.34597275 |
| 20 | MP0003137_abnormal_impulse_conducting | 2.31450051 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.22906110 |
| 22 | MP0003221_abnormal_cardiomyocyte_apopto | 2.12278635 |
| 23 | MP0010630_abnormal_cardiac_muscle | 2.08654526 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 2.06971155 |
| 25 | MP0008932_abnormal_embryonic_tissue | 2.03382842 |
| 26 | MP0003077_abnormal_cell_cycle | 2.02707235 |
| 27 | MP0000750_abnormal_muscle_regeneration | 2.01713670 |
| 28 | MP0008260_abnormal_autophagy | 2.00549703 |
| 29 | MP0005332_abnormal_amino_acid | 1.99586514 |
| 30 | MP0002972_abnormal_cardiac_muscle | 1.95781578 |
| 31 | MP0001661_extended_life_span | 1.95196614 |
| 32 | MP0002106_abnormal_muscle_physiology | 1.87742159 |
| 33 | MP0001544_abnormal_cardiovascular_syste | 1.87094441 |
| 34 | MP0005385_cardiovascular_system_phenoty | 1.87094441 |
| 35 | MP0000747_muscle_weakness | 1.84960349 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.82377107 |
| 37 | MP0005620_abnormal_muscle_contractility | 1.79648021 |
| 38 | MP0009840_abnormal_foam_cell | 1.79450621 |
| 39 | MP0005670_abnormal_white_adipose | 1.77941935 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.70663710 |
| 41 | MP0006035_abnormal_mitochondrial_morpho | 1.70643046 |
| 42 | MP0005501_abnormal_skin_physiology | 1.69396616 |
| 43 | MP0004858_abnormal_nervous_system | 1.63742558 |
| 44 | MP0005266_abnormal_metabolism | 1.61704910 |
| 45 | MP0008007_abnormal_cellular_replicative | 1.58817026 |
| 46 | MP0000003_abnormal_adipose_tissue | 1.57662014 |
| 47 | MP0000759_abnormal_skeletal_muscle | 1.56201127 |
| 48 | MP0006138_congestive_heart_failure | 1.55107480 |
| 49 | MP0003567_abnormal_fetal_cardiomyocyte | 1.53089254 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.50448845 |
| 51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49565419 |
| 52 | MP0000678_abnormal_parathyroid_gland | 1.47315497 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.46454331 |
| 54 | MP0005369_muscle_phenotype | 1.44497995 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.43214093 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 1.42264648 |
| 57 | MP0002796_impaired_skin_barrier | 1.42098212 |
| 58 | MP0003828_pulmonary_edema | 1.40468215 |
| 59 | MP0010329_abnormal_lipoprotein_level | 1.37056253 |
| 60 | MP0008058_abnormal_DNA_repair | 1.30059601 |
| 61 | MP0005083_abnormal_biliary_tract | 1.29061134 |
| 62 | MP0000350_abnormal_cell_proliferation | 1.25285594 |
| 63 | MP0004185_abnormal_adipocyte_glucose | 1.22157209 |
| 64 | MP0004484_altered_response_of | 1.22039943 |
| 65 | MP0010030_abnormal_orbit_morphology | 1.21125891 |
| 66 | MP0003186_abnormal_redox_activity | 1.19196339 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.18643633 |
| 68 | MP0002127_abnormal_cardiovascular_syste | 1.17996342 |
| 69 | MP0003195_calcinosis | 1.17927372 |
| 70 | MP0003123_paternal_imprinting | 1.17506851 |
| 71 | MP0003786_premature_aging | 1.17099211 |
| 72 | MP0000733_abnormal_muscle_development | 1.16426726 |
| 73 | MP0003315_abnormal_perineum_morphology | 1.14522784 |
| 74 | MP0001727_abnormal_embryo_implantation | 1.14455084 |
| 75 | MP0000537_abnormal_urethra_morphology | 1.12981471 |
| 76 | MP0004043_abnormal_pH_regulation | 1.11168822 |
| 77 | MP0000313_abnormal_cell_death | 1.09678202 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.09051838 |
| 79 | MP0004957_abnormal_blastocyst_morpholog | 1.08442601 |
| 80 | MP0002971_abnormal_brown_adipose | 1.07783682 |
| 81 | MP0002118_abnormal_lipid_homeostasis | 1.07391740 |
| 82 | MP0001666_abnormal_nutrient_absorption | 1.06556002 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03662510 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 1.02151562 |
| 85 | MP0004085_abnormal_heartbeat | 1.01879834 |
| 86 | MP0003252_abnormal_bile_duct | 1.01453539 |
| 87 | MP0000490_abnormal_crypts_of | 1.01430685 |
| 88 | MP0000609_abnormal_liver_physiology | 1.01142342 |
| 89 | MP0009643_abnormal_urine_homeostasis | 0.99019311 |
| 90 | MP0005375_adipose_tissue_phenotype | 0.98390135 |
| 91 | MP0004019_abnormal_vitamin_homeostasis | 0.96814697 |
| 92 | MP0003191_abnormal_cellular_cholesterol | 0.96175247 |
| 93 | MP0000013_abnormal_adipose_tissue | 0.93599153 |
| 94 | MP0008057_abnormal_DNA_replication | 0.93316637 |
| 95 | MP0009672_abnormal_birth_weight | 0.93040110 |
| 96 | MP0000266_abnormal_heart_morphology | 0.91652737 |
| 97 | MP0000858_altered_metastatic_potential | 0.90591869 |
| 98 | MP0005165_increased_susceptibility_to | 0.90128225 |
| 99 | MP0001849_ear_inflammation | 0.89307443 |
| 100 | MP0001730_embryonic_growth_arrest | 0.85698948 |
| 101 | MP0001346_abnormal_lacrimal_gland | 0.84424599 |
| 102 | MP0001764_abnormal_homeostasis | 0.84367804 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.83265433 |
| 104 | MP0002019_abnormal_tumor_incidence | 0.82163254 |
| 105 | MP0003984_embryonic_growth_retardation | 0.81951563 |
| 106 | MP0000343_altered_response_to | 0.81426341 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.80589117 |
| 108 | MP0009697_abnormal_copulation | 0.80550910 |
| 109 | MP0002088_abnormal_embryonic_growth/wei | 0.79787392 |
| 110 | MP0003693_abnormal_embryo_hatching | 0.78114365 |
| 111 | MP0004133_heterotaxia | 0.77844032 |
| 112 | MP0001697_abnormal_embryo_size | 0.76184752 |
| 113 | MP0002249_abnormal_larynx_morphology | 0.76026367 |
| 114 | MP0005380_embryogenesis_phenotype | 0.75859181 |
| 115 | MP0001672_abnormal_embryogenesis/_devel | 0.75859181 |
| 116 | MP0004147_increased_porphyrin_level | 0.75469961 |
| 117 | MP0002970_abnormal_white_adipose | 0.74809618 |
| 118 | MP0005451_abnormal_body_composition | 0.72839825 |
| 119 | MP0009278_abnormal_bone_marrow | 0.72224046 |
| 120 | MP0000358_abnormal_cell_content/ | 0.70628543 |
| 121 | MP0002078_abnormal_glucose_homeostasis | 0.69547621 |
| 122 | MP0001881_abnormal_mammary_gland | 0.67917748 |
| 123 | MP0000598_abnormal_liver_morphology | 0.67859117 |
| 124 | MP0003329_amyloid_beta_deposits | 0.67275631 |
| 125 | MP0009115_abnormal_fat_cell | 0.66132569 |
| 126 | MP0003283_abnormal_digestive_organ | 0.66130338 |
| 127 | MP0002060_abnormal_skin_morphology | 0.64612242 |
| 128 | MP0005384_cellular_phenotype | 0.64195595 |
| 129 | MP0002822_catalepsy | 0.64083620 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.64024811 |
| 131 | MP0002086_abnormal_extraembryonic_tissu | 0.63895910 |
| 132 | MP0002080_prenatal_lethality | 0.62970704 |
| 133 | MP0010352_gastrointestinal_tract_polyps | 0.59634560 |
| 134 | MP0001756_abnormal_urination | 0.58486380 |
| 135 | MP0003119_abnormal_digestive_system | 0.58059391 |
| 136 | MP0003111_abnormal_nucleus_morphology | 0.56463995 |
| 137 | MP0005535_abnormal_body_temperature | 0.52562691 |
| 138 | MP0010094_abnormal_chromosome_stability | 0.51227804 |
| 139 | MP0004197_abnormal_fetal_growth/weight/ | 0.48814375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myoglobinuria (HP:0002913) | 5.06762792 |
| 2 | Sudden death (HP:0001699) | 4.95764700 |
| 3 | Exercise-induced myalgia (HP:0003738) | 4.66364026 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 4.33017952 |
| 5 | Rhabdomyolysis (HP:0003201) | 4.26351255 |
| 6 | Ventricular tachycardia (HP:0004756) | 4.24020862 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 4.08433861 |
| 8 | Nemaline bodies (HP:0003798) | 4.06715733 |
| 9 | Myopathic facies (HP:0002058) | 4.04112896 |
| 10 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.03718052 |
| 11 | Hepatic necrosis (HP:0002605) | 3.96799819 |
| 12 | Hyperglycinuria (HP:0003108) | 3.73551323 |
| 13 | Hypoglycemic coma (HP:0001325) | 3.70928015 |
| 14 | Palpitations (HP:0001962) | 3.68183078 |
| 15 | Distal lower limb muscle weakness (HP:0009053) | 3.66074039 |
| 16 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.65379440 |
| 17 | Calf muscle hypertrophy (HP:0008981) | 3.59747640 |
| 18 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.59287842 |
| 19 | Dicarboxylic aciduria (HP:0003215) | 3.59287842 |
| 20 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.55623424 |
| 21 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.51896490 |
| 22 | Acute encephalopathy (HP:0006846) | 3.49450679 |
| 23 | Cerebral edema (HP:0002181) | 3.39734701 |
| 24 | Hepatocellular necrosis (HP:0001404) | 3.36096797 |
| 25 | Lipoatrophy (HP:0100578) | 3.33929772 |
| 26 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.32335777 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 3.32149606 |
| 28 | * Hyperammonemia (HP:0001987) | 3.32108638 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.31325335 |
| 30 | Increased muscle lipid content (HP:0009058) | 3.30819305 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.20263346 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.20263346 |
| 33 | Abnormal gallbladder physiology (HP:0012438) | 3.18305932 |
| 34 | Cholecystitis (HP:0001082) | 3.18305932 |
| 35 | Muscle fiber splitting (HP:0003555) | 3.18085033 |
| 36 | Microvesicular hepatic steatosis (HP:0001414) | 3.13763324 |
| 37 | Right ventricular cardiomyopathy (HP:0011663) | 3.07957103 |
| 38 | Ragged-red muscle fibers (HP:0003200) | 3.07526610 |
| 39 | Atrial fibrillation (HP:0005110) | 3.02418555 |
| 40 | * Ketosis (HP:0001946) | 3.02405502 |
| 41 | Distal lower limb amyotrophy (HP:0008944) | 2.92948142 |
| 42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.92268399 |
| 43 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.92268399 |
| 44 | Increased CSF lactate (HP:0002490) | 2.91412732 |
| 45 | Dilated cardiomyopathy (HP:0001644) | 2.90315883 |
| 46 | Increased serum pyruvate (HP:0003542) | 2.89772965 |
| 47 | Abnormality of glycolysis (HP:0004366) | 2.89772965 |
| 48 | * Ketoacidosis (HP:0001993) | 2.88461394 |
| 49 | Mitochondrial inheritance (HP:0001427) | 2.87802412 |
| 50 | * Lactic acidosis (HP:0003128) | 2.87270154 |
| 51 | Increased intramyocellular lipid droplets (HP:0012240) | 2.86044294 |
| 52 | Hyporeflexia of lower limbs (HP:0002600) | 2.85817576 |
| 53 | Supraventricular tachycardia (HP:0004755) | 2.85741704 |
| 54 | Lethargy (HP:0001254) | 2.85638434 |
| 55 | Primary atrial arrhythmia (HP:0001692) | 2.82781790 |
| 56 | Testicular atrophy (HP:0000029) | 2.80415703 |
| 57 | Abnormality of the calf musculature (HP:0001430) | 2.80195470 |
| 58 | Supraventricular arrhythmia (HP:0005115) | 2.80161486 |
| 59 | Ventricular arrhythmia (HP:0004308) | 2.77089893 |
| 60 | Type 1 muscle fiber predominance (HP:0003803) | 2.75939036 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.74367303 |
| 62 | Hyperglycinemia (HP:0002154) | 2.73171715 |
| 63 | Multiple enchondromatosis (HP:0005701) | 2.71150343 |
| 64 | Subaortic stenosis (HP:0001682) | 2.70057045 |
| 65 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.70057045 |
| 66 | Muscle stiffness (HP:0003552) | 2.70035347 |
| 67 | Achilles tendon contracture (HP:0001771) | 2.69664882 |
| 68 | Syncope (HP:0001279) | 2.67308196 |
| 69 | Nausea (HP:0002018) | 2.66367360 |
| 70 | Neck muscle weakness (HP:0000467) | 2.60729915 |
| 71 | Bundle branch block (HP:0011710) | 2.59517245 |
| 72 | Increased connective tissue (HP:0009025) | 2.57469763 |
| 73 | Progressive macrocephaly (HP:0004481) | 2.55214736 |
| 74 | Exercise intolerance (HP:0003546) | 2.52542246 |
| 75 | Cholelithiasis (HP:0001081) | 2.49825385 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.47603053 |
| 77 | Metabolic acidosis (HP:0001942) | 2.47554070 |
| 78 | Respiratory failure (HP:0002878) | 2.47009641 |
| 79 | Conjunctival hamartoma (HP:0100780) | 2.46529058 |
| 80 | Ventricular fibrillation (HP:0001663) | 2.43708990 |
| 81 | Abnormality of the Achilles tendon (HP:0005109) | 2.43045158 |
| 82 | Gout (HP:0001997) | 2.41984320 |
| 83 | EMG: myopathic abnormalities (HP:0003458) | 2.41390573 |
| 84 | Myotonia (HP:0002486) | 2.40908956 |
| 85 | Proximal tubulopathy (HP:0000114) | 2.40624884 |
| 86 | Atrioventricular block (HP:0001678) | 2.40485350 |
| 87 | Progressive muscle weakness (HP:0003323) | 2.39075916 |
| 88 | Pheochromocytoma (HP:0002666) | 2.35722767 |
| 89 | Trismus (HP:0000211) | 2.35558492 |
| 90 | Heart block (HP:0012722) | 2.34800889 |
| 91 | Vomiting (HP:0002013) | 2.34755743 |
| 92 | CNS demyelination (HP:0007305) | 2.34038160 |
| 93 | Reticulocytosis (HP:0001923) | 2.32293246 |
| 94 | Abnormality of alanine metabolism (HP:0010916) | 2.32176120 |
| 95 | Hyperalaninemia (HP:0003348) | 2.32176120 |
| 96 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.32176120 |
| 97 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.30502982 |
| 98 | * Increased serum lactate (HP:0002151) | 2.29345974 |
| 99 | Bulbar palsy (HP:0001283) | 2.28052371 |
| 100 | Prolonged QT interval (HP:0001657) | 2.23479058 |
| 101 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.22347306 |
| 102 | Vertebral compression fractures (HP:0002953) | 2.21848780 |
| 103 | Hypobetalipoproteinemia (HP:0003563) | 2.20814541 |
| 104 | Difficulty climbing stairs (HP:0003551) | 2.19755638 |
| 105 | Hyperacusis (HP:0010780) | 2.18699097 |
| 106 | Abnormal atrioventricular conduction (HP:0005150) | 2.17433238 |
| 107 | Neoplasm of the adrenal gland (HP:0100631) | 2.16113359 |
| 108 | Neuroendocrine neoplasm (HP:0100634) | 2.15420132 |
| 109 | Lipid accumulation in hepatocytes (HP:0006561) | 2.14773291 |
| 110 | Progressive external ophthalmoplegia (HP:0000590) | 2.14184111 |
| 111 | Diaphragmatic weakness (HP:0009113) | 2.13390639 |
| 112 | Abnormality of serum amino acid levels (HP:0003112) | 2.13356942 |
| 113 | Late onset (HP:0003584) | 2.12449837 |
| 114 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.11078335 |
| 115 | Abnormal gallbladder morphology (HP:0012437) | 2.10092714 |
| 116 | Abnormality of the tricuspid valve (HP:0001702) | 2.08611846 |
| 117 | Xanthomatosis (HP:0000991) | 2.07317915 |
| 118 | Difficulty running (HP:0009046) | 2.06895284 |
| 119 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.05147593 |
| 120 | Abnormality of reticulocytes (HP:0004312) | 2.04290984 |
| 121 | Hypolipoproteinemia (HP:0010981) | 2.04251150 |
| 122 | Type I transferrin isoform profile (HP:0003642) | 2.03641202 |
| 123 | Esophageal neoplasm (HP:0100751) | 2.03448714 |
| 124 | Neoplasm of head and neck (HP:0012288) | 2.03448714 |
| 125 | Abnormal number of erythroid precursors (HP:0012131) | 2.01181049 |
| 126 | Athetosis (HP:0002305) | 2.01100809 |
| 127 | Generalized amyotrophy (HP:0003700) | 1.99708517 |
| 128 | Rough bone trabeculation (HP:0100670) | 1.98100712 |
| 129 | Delayed CNS myelination (HP:0002188) | 1.97674835 |
| 130 | Hypoalphalipoproteinemia (HP:0003233) | 1.97168327 |
| 131 | Increased hepatocellular lipid droplets (HP:0006565) | 1.97127792 |
| 132 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.96103694 |
| 133 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.95061560 |
| 134 | Intrahepatic cholestasis (HP:0001406) | 1.93319304 |
| 135 | Reduced antithrombin III activity (HP:0001976) | 1.90861203 |
| 136 | Hypokinesia (HP:0002375) | 1.90621756 |
| 137 | Rimmed vacuoles (HP:0003805) | 1.90513639 |
| 138 | Hypertensive crisis (HP:0100735) | 1.85921698 |
| 139 | Insomnia (HP:0100785) | 1.83401452 |
| 140 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.82192473 |
| 141 | Microretrognathia (HP:0000308) | 1.81245080 |
| 142 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.80341562 |
| 143 | Fasciculations (HP:0002380) | 1.80210035 |
| 144 | Lower limb amyotrophy (HP:0007210) | 1.78109038 |
| 145 | Abnormality of the gallbladder (HP:0005264) | 1.78074967 |
| 146 | Abnormality of the umbilical cord (HP:0010881) | 1.77901134 |
| 147 | Calcaneovalgus deformity (HP:0001848) | 1.77721660 |
| 148 | Round ear (HP:0100830) | 1.77620327 |
| 149 | Foot dorsiflexor weakness (HP:0009027) | 1.75158944 |
| 150 | Emotional lability (HP:0000712) | 1.73877813 |
| 151 | Truncus arteriosus (HP:0001660) | 1.72100693 |
| 152 | Limb-girdle muscle atrophy (HP:0003797) | 1.69978212 |
| 153 | Ulnar deviation of the wrist (HP:0003049) | 1.69167880 |
| 154 | Abnormality of the foot musculature (HP:0001436) | 1.64159109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.84582062 |
| 2 | NEK1 | 3.57008875 |
| 3 | TRIB3 | 3.34363883 |
| 4 | TTN | 3.14040775 |
| 5 | PINK1 | 3.01128612 |
| 6 | PDK3 | 2.97299506 |
| 7 | PDK4 | 2.97299506 |
| 8 | IRAK3 | 2.91981302 |
| 9 | MAP3K11 | 2.91625696 |
| 10 | ICK | 2.90348262 |
| 11 | PKN2 | 2.89471078 |
| 12 | OBSCN | 2.88005907 |
| 13 | PHKG2 | 2.86797321 |
| 14 | PHKG1 | 2.86797321 |
| 15 | VRK2 | 2.80978992 |
| 16 | LMTK2 | 2.58627689 |
| 17 | SMG1 | 2.51123264 |
| 18 | TESK1 | 2.48513259 |
| 19 | ARAF | 2.11165202 |
| 20 | MYLK | 2.10026844 |
| 21 | MST1R | 1.91017778 |
| 22 | MAP3K6 | 1.77641165 |
| 23 | EEF2K | 1.77103924 |
| 24 | DDR2 | 1.63132169 |
| 25 | MAPK15 | 1.56304448 |
| 26 | LIMK1 | 1.56253093 |
| 27 | PDK2 | 1.53418768 |
| 28 | PBK | 1.53296534 |
| 29 | NME2 | 1.50611863 |
| 30 | MAPKAPK3 | 1.38071871 |
| 31 | KDR | 1.34539739 |
| 32 | PRPF4B | 1.32736256 |
| 33 | BUB1 | 1.31276677 |
| 34 | SRPK1 | 1.21844987 |
| 35 | FLT3 | 1.16896347 |
| 36 | LATS2 | 1.16762619 |
| 37 | STK16 | 1.16516220 |
| 38 | STK38L | 1.15327243 |
| 39 | MAPK11 | 1.12627958 |
| 40 | DAPK1 | 1.12166120 |
| 41 | PDGFRA | 1.12092965 |
| 42 | ERN1 | 1.11468157 |
| 43 | WEE1 | 1.10760813 |
| 44 | MAP3K10 | 1.05436194 |
| 45 | CDC7 | 1.03828166 |
| 46 | MAP2K3 | 1.02126624 |
| 47 | ILK | 1.01939141 |
| 48 | DMPK | 1.01739586 |
| 49 | BRAF | 1.01509546 |
| 50 | PIM2 | 0.99863234 |
| 51 | CDK8 | 0.97388480 |
| 52 | CDC42BPA | 0.93670215 |
| 53 | NME1 | 0.93348155 |
| 54 | CCNB1 | 0.93339293 |
| 55 | TAOK2 | 0.91405867 |
| 56 | PRKAA1 | 0.89667373 |
| 57 | WNK4 | 0.89086217 |
| 58 | EIF2AK1 | 0.88754360 |
| 59 | MATK | 0.83131843 |
| 60 | STK24 | 0.82515403 |
| 61 | UHMK1 | 0.81775926 |
| 62 | BMX | 0.81400466 |
| 63 | DYRK1B | 0.78603029 |
| 64 | TYRO3 | 0.75491250 |
| 65 | SIK1 | 0.75288458 |
| 66 | MAP3K5 | 0.75153698 |
| 67 | RPS6KL1 | 0.71281133 |
| 68 | RPS6KC1 | 0.71281133 |
| 69 | CDK7 | 0.70792336 |
| 70 | TIE1 | 0.70748035 |
| 71 | MAP3K3 | 0.68079416 |
| 72 | MET | 0.66036167 |
| 73 | RPS6KB2 | 0.64750654 |
| 74 | DAPK3 | 0.64550053 |
| 75 | RIPK1 | 0.63812500 |
| 76 | AKT2 | 0.62653276 |
| 77 | TESK2 | 0.62097089 |
| 78 | TBK1 | 0.61575667 |
| 79 | TAOK1 | 0.61132565 |
| 80 | TTK | 0.60953765 |
| 81 | BRSK1 | 0.60560034 |
| 82 | CAMK2D | 0.59969952 |
| 83 | CHEK2 | 0.59789090 |
| 84 | PRKD1 | 0.59080549 |
| 85 | RPS6KA6 | 0.58012294 |
| 86 | PAK1 | 0.57895853 |
| 87 | PRKAA2 | 0.56121510 |
| 88 | PAK4 | 0.55895750 |
| 89 | TSSK6 | 0.55761956 |
| 90 | PRKCI | 0.55618848 |
| 91 | CDK4 | 0.54464732 |
| 92 | CAMK2G | 0.53530079 |
| 93 | PLK1 | 0.51978039 |
| 94 | SCYL2 | 0.51740510 |
| 95 | VRK1 | 0.51478382 |
| 96 | MTOR | 0.51342279 |
| 97 | MAPKAPK5 | 0.50681296 |
| 98 | MAPK12 | 0.50323042 |
| 99 | RPS6KA1 | 0.50272612 |
| 100 | ATR | 0.50140409 |
| 101 | PRKD2 | 0.50124504 |
| 102 | CSNK1G3 | 0.49342669 |
| 103 | AURKA | 0.48753562 |
| 104 | IRAK2 | 0.46849920 |
| 105 | CDK11A | 0.46705468 |
| 106 | PDPK1 | 0.46630707 |
| 107 | MAP3K8 | 0.45886074 |
| 108 | RPS6KA4 | 0.44873735 |
| 109 | RPS6KA5 | 0.44852695 |
| 110 | STK4 | 0.44681908 |
| 111 | EPHA2 | 0.44653357 |
| 112 | MAP3K1 | 0.44170018 |
| 113 | PIK3CA | 0.44021235 |
| 114 | PTK2 | 0.42927287 |
| 115 | STK38 | 0.42633271 |
| 116 | LRRK2 | 0.42464509 |
| 117 | MAP3K7 | 0.42142963 |
| 118 | CDK15 | 0.42126872 |
| 119 | AURKB | 0.41613062 |
| 120 | MAP3K12 | 0.40213308 |
| 121 | MAP2K6 | 0.39859040 |
| 122 | DYRK3 | 0.39779574 |
| 123 | CDK14 | 0.39457700 |
| 124 | CDK18 | 0.38547762 |
| 125 | MUSK | 0.38530484 |
| 126 | PRKACG | 0.36869862 |
| 127 | ABL2 | 0.36844351 |
| 128 | MAP2K2 | 0.36544687 |
| 129 | PAK3 | 0.36215686 |
| 130 | CSK | 0.36150188 |
| 131 | TRPM7 | 0.35672852 |
| 132 | CDK6 | 0.35149642 |
| 133 | KSR2 | 0.35088972 |
| 134 | GSK3A | 0.34679120 |
| 135 | NEK2 | 0.34580849 |
| 136 | WNK3 | 0.34348193 |
| 137 | PTK6 | 0.33878672 |
| 138 | CHEK1 | 0.33674207 |
| 139 | MOS | 0.33468694 |
| 140 | FGFR4 | 0.32947392 |
| 141 | CSNK2A2 | 0.32367829 |
| 142 | CDK12 | 0.31690813 |
| 143 | FGR | 0.31120740 |
| 144 | CSNK1A1L | 0.30418867 |
| 145 | CSNK2A1 | 0.30156416 |
| 146 | PRKG2 | 0.29434691 |
| 147 | RAF1 | 0.28077619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.87674697 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.53236804 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.20755782 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.02280023 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.93109986 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.84923299 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.80585102 |
| 8 | Carbon metabolism_Homo sapiens_hsa01200 | 2.74123003 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.54293382 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.33723180 |
| 11 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.32320828 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.31082732 |
| 13 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.23257511 |
| 14 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.01853026 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.88585790 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82361795 |
| 17 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.68490985 |
| 18 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.60760020 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.58293412 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.49901317 |
| 21 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.49265253 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.47821456 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.45943784 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.44643906 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42690892 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.41910377 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.38251490 |
| 28 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.37164762 |
| 29 | DNA replication_Homo sapiens_hsa03030 | 1.35103474 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32638946 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31465955 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.29095547 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.28944426 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 1.28636635 |
| 35 | Mismatch repair_Homo sapiens_hsa03430 | 1.27086990 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26695974 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22483588 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22032306 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.20023616 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17947559 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16204170 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13386162 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11140139 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.09553394 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07818293 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06613102 |
| 47 | Proteasome_Homo sapiens_hsa03050 | 1.02951965 |
| 48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.01909737 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01338584 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00330225 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99831602 |
| 52 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99396273 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99256891 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96668136 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94467673 |
| 56 | Purine metabolism_Homo sapiens_hsa00230 | 0.91619250 |
| 57 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.90243507 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89365267 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89236608 |
| 60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.88373311 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.87164836 |
| 62 | Cell cycle_Homo sapiens_hsa04110 | 0.86214689 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.86057728 |
| 64 | Ribosome_Homo sapiens_hsa03010 | 0.86057536 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84123683 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81620617 |
| 67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77105142 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76894837 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69147241 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65781978 |
| 71 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.65369668 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64191076 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62835397 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.61112086 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57377705 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57216577 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56229331 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.54619644 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53676753 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51886527 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50481846 |
| 82 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49917900 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49407868 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46121882 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46043596 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45458936 |
| 87 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.44881442 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.43079562 |
| 89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42994270 |
| 90 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.42960276 |
| 91 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42671706 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42370712 |
| 93 | RNA transport_Homo sapiens_hsa03013 | 0.42342494 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42210522 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41560421 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40760519 |
| 97 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.40035453 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40003279 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39637273 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38915516 |
| 101 | Spliceosome_Homo sapiens_hsa03040 | 0.36828436 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.36021350 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35285540 |
| 104 | Viral myocarditis_Homo sapiens_hsa05416 | 0.33096388 |
| 105 | Alcoholism_Homo sapiens_hsa05034 | 0.32888965 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32636988 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32399786 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31350980 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31252686 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.29171770 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.27999641 |
| 112 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.26627545 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25711565 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25645657 |
| 115 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.23108960 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22351080 |
| 117 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.21954668 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19887950 |
| 119 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.19435726 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18510039 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.18393030 |
| 122 | Retinol metabolism_Homo sapiens_hsa00830 | 0.17952697 |
| 123 | Apoptosis_Homo sapiens_hsa04210 | 0.17774950 |
| 124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.16571237 |
| 125 | Homologous recombination_Homo sapiens_hsa03440 | 0.16421065 |
| 126 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.15291708 |
| 127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15105179 |
| 128 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.14813675 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.13349009 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.13042079 |
| 131 | Tight junction_Homo sapiens_hsa04530 | 0.12435892 |
| 132 | Bladder cancer_Homo sapiens_hsa05219 | 0.12303013 |

